Verified Nov 2026
Electronics & Software
·
Norcross, Georgia
·
Since 1966
Immucor, Inc. manufactures in vitro diagnostic instruments, reagents, and automation systems for hemostasis, acute care, autoimmunity, and transfusion diagnostics. Headquartered in Norcross, Georgia and founded in 1966, the company operates as part of Werfen, a family-owned corporation based in Barcelona. With 5,000–10,000 employees and estimated revenue of $1–5 billion, Immucor serves hospitals, clinical laboratories, and research institutions across nearly 30 countries in the medical and industrial-equipment sectors. In April 2025, Immucor Italia merged with Werfen Instrumentation Laboratory.
Immucor, Inc. at a glance
Revenue
$1-5B
Est. band
Employees
5,000-10,000
Founded
1966
Headquarters
Norcross, Georgia
Certifications
ISO 13485
Import activity
60
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
60
Named foreign suppliers
4
Top origins
Germany · Belgium · Netherlands
Shared foreign counterparties do not establish that these companies buy from Immucor, Inc..
What this tells a buyer
Immucor received 60 recorded shipments, predominantly from Germany-based suppliers including Stratec Biomedical (54 shipments), with additional origins in Belgium and the Netherlands.
The company produces automated testing systems, diagnostic reagents, and integrated data management solutions; it holds ISO 13485 certification for medical device quality.
Immucor operates within Werfen, a family-owned organization with approximately 7,000 employees across five primary diagnostic business lines serving the healthcare sector globally.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
60 years in operation (founded 1966).
60 US import shipments on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Immucor, Inc. manufactures in vitro diagnostic instruments, reagents, and automation systems for hemostasis, acute care, autoimmunity, and transfusion diagnostics. Headquartered in Norcross, Georgia and founded in 1966, the company operates as part of Werfen, a family-owned corporation based in Barcelona. With 5,000–10,000 employees and estimated revenue of $1–5 billion, Immucor serves hospitals, clinical laboratories, and research institutions across nearly 30 countries in the medical and industrial-equipment sectors. In April 2025, Immucor Italia merged with Werfen Instrumentation Laboratory.
At a glance
Attribute | Detail |
|---|---|
Founded | 1966 |
Headquarters | Norcross, Georgia |
Employees | 5,000-10,000 |
Revenue | $1-5B (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 |
What Immucor, Inc. makes
The company produces automated testing systems, diagnostic reagents, and integrated data management solutions; it holds ISO 13485 certification for medical device quality.
Certifications
Immucor, Inc. is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — werfen.com
Trade and customs footprint
Immucor received 60 recorded shipments, predominantly from Germany-based suppliers including Stratec Biomedical (54 shipments), with additional origins in Belgium and the Netherlands. US customs bill-of-lading records list 60 inbound shipments across 4 foreign suppliers, with top origins including Germany · Belgium · Netherlands.
Latest developments
2025-04-02 — PRESA DATTO DELLA FUSIONE AZIENDALE DELLA SOCIETA' IMMUCOR ITALIA SPA CON LA SOCIETA' WERFEN INSTRUMENTATION LABORATORY SPA E DEL CONSEGUENTE SUBENTRO DI QUEST'ULTIMA NEI CONTRATTI AFFIDATI ALLA SOCIETA' PRECEDENTE | ASST Santi Paolo e Carlo (asst-santipaolocarlo.it)
2025-01-29 — PA IMMUNOEMATOLOGIA – aggiudicazione a Immucor Italia S.p.A. (tenderroster.com)
Company details
Immucor operates within Werfen, a family-owned organization with approximately 7,000 employees across five primary diagnostic business lines serving the healthcare sector globally. Immucor, Inc. was founded in 1966, has an estimated 5,000-10,000 employees, and is headquartered in Norcross, Georgia. On the LightSource stability read it is rated "Established & active": 60 years in operation (founded 1966). 60 US import shipments on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Immucor, Inc. make?
Immucor, Inc. manufactures in vitro diagnostic instruments, reagents, and automation systems for hemostasis, acute care, autoimmunity, and transfusion diagnostics. Headquartered in Norcross, Georgia and founded in 1966, the company operates as part of Werfen, a family-owned corporation based in Barcelona. With 5,000–10,000 employees and estimated revenue of $1–5 billion, Immucor serves hospitals, clinical laboratories, and research institutions across nearly 30 countries in the medical and industrial-equipment sectors. In April 2025, Immucor Italia merged with Werfen Instrumentation Laboratory.
Where is Immucor, Inc. headquartered?
Immucor, Inc. is headquartered in Norcross, Georgia.
When was Immucor, Inc. founded?
Immucor, Inc. was founded in 1966.
How big is Immucor, Inc.?
Immucor, Inc. has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Immucor, Inc. hold?
Immucor, Inc. lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does Immucor, Inc. import from overseas suppliers?
US customs bill-of-lading records show 60 inbound shipments for Immucor, Inc., with top origins including Germany · Belgium · Netherlands.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.